Stock Track | ScanSource Plunges 6.85% Pre-Market Despite EPS Beat as Q1 Sales Miss Estimates

Stock Track
Nov 06, 2025

ScanSource (NASDAQ: SCSC) saw its stock price plummet 6.85% in pre-market trading on Thursday, following the release of its first-quarter earnings report. Despite beating earnings per share (EPS) estimates, the company's sales figures fell short of expectations, raising concerns among investors.

The technology products distributor reported adjusted earnings of $1.06 per share, surpassing the analyst consensus estimate of $0.93 by 13.98%. This represents a 26.19% increase from the $0.84 per share earned in the same period last year. However, ScanSource's quarterly sales of $739.650 million missed the analyst consensus estimate of $787.367 million by 6.06%. More worryingly, this figure represents a 4.63% decrease compared to sales of $775.580 million in the same quarter of the previous year.

While ScanSource's bottom line performance was strong, with adjusted net income reaching $23.685 million and adjusted EBITDA at $38.59 million, the market appears to be focusing on the company's top-line weakness. The significant miss on sales estimates and the year-over-year revenue decline seem to be the primary drivers behind the stock's pre-market plunge. Despite these challenges, ScanSource has reaffirmed its guidance for the fiscal year 2026, suggesting management's confidence in the company's long-term prospects. Investors will likely be watching closely to see if ScanSource can reverse its sales trend in the coming quarters.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10